SuperworthAngiodynamics market cap ANGO
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $520M
- Highest close in our data
- $1.2B
- Nov 2021
Angiodynamics is worth $520M at the close on Oct 23, 2026, at $12.37 a share.
That is up 2% over the last year and down 53% over five years.
Its highest close in our data was $1.2B in Nov 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $520M | $404.9M | $655.1M | −4% |
| 2025 | $539.7M | $345.8M | $555M | +49% |
| 2024 | $362.1M | $213.6M | $365.7M | +16% |
| 2023 | $312.4M | $247.4M | $593.3M | −42% |
| 2022 | $538.5M | $477.1M | $944.2M | −49% |
| 2021 | $1.1B | $683.7M | $1.2B | +83% |
| 2020 | $581.8M | $311.4M | $620.4M | −3% |
| 2019 | $600M | $535.3M | $871.2M | −20% |
| 2018 | $749.1M | $592M | $877.1M | +23% |
| 2017 | $610.6M | $558.7M | $661.6M | −2% |
| 2016 | $622.2M | $372.7M | $639.2M | +41% |
| 2015 | $440.4M | $412.1M | $689.4M | −36% |
| 2014 | $683.5M | $471.2M | $683.5M | +16% |
| 2013 | $589.1M | $338.6M | $589.1M | +55% |
| 2012 | $381.2M | $269.6M | $435.7M | +2% |
| 2011 | $373.4M | $338.4M | $401.2M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Angiodynamics' size, closest first, today.
| Company | Market cap |
|---|---|
| ANGOAngiodynamics | $520M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| EMBCEmbecta | $380.2M |
| INFUInfuSystem | $277.6M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| UTMDUtah Medical Products | $236.3M |
| BVSBioventus | $1.3B |
| CDRECadre | $1.3B |
| Peer median | $635.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Angiodynamics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.